Alphamab Oncology (stock code: 9966.HK) announced that the biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003, independently developed by the Company, and co-developed with JMT-Bio ...

The CUTX-101 NDA was initially granted Priority Review by the FDA and is supported by positive topline clinical efficacy results for CUTX-101, demonstrating significant improvement in overall survival ...

Sentynl Therapeutics, Inc. ("Sentynl"), a U.S.-based biopharmaceutical company wholly-owned by Zydus Lifesciences, Ltd. ("Zydus Group"), today announced that the U.S. Food and Drug Administration (FDA ...

Dyne Therapeutics, Inc.’s 2026 outlook with key DYNE-101/251 data, FDA submission plans, and extended cash runway. Click for ...

Arovella Therapeutics Limited ( ($AU:ALA) ) has shared an announcement. Arovella Therapeutics Limited has issued 371,187 ordinary shares without ...

Triple-therapy immunotherapy approaches are demonstrating complete leukemia elimination in preclinical models by reprogramming how cancer cells die to trigger powerful immune responses([1]) , while ...

In a major leap for genomic medicine and the government’s commitment to tribal health, India on Wednesday launched its first indigenous CRISPR-based gene therapy aimed at eradicating Sickle Cell ...

New Delhi, Nov 19: In a major leap for Atmanirbhar Bharat and India’s genomic medicine capabilities, the government on Wednesday launched the country’s first indigenous CRISPR-based gene therapy for ...

CoTx-101 targets retinal vascular diseases using a novel vector, coAAV-SCS, for enhanced retinal penetration and sustained biologic expression. Coave Therapeutics plans to complete non-human primate ...

Kyverna Therapeutics has reported deep, sustained improvements in autoimmune disease patients who received a single dose of its CAR T-cell therapy KYV-101. The data come from the phase 2 part of a ...

Microbiotix Co. Ltd. has obtained IND approval from the Korean Ministry of Food and Drug Safety (MFDS) for MP-101, a bacteriophage therapy for patients with acute pneumonia. A phase I study in adult ...

There are several stereotypes or stigmas surrounding therapy. These include the belief that “therapy is for the weak,” “medication is for crazy people,” and that it should only be done as “a last ...